S. Shah

The Discovery and Biologic Properties of Cephalosporin‐Based Inhibitors of PMN Elastase

M. Navia, W. Hanlon, E. Opas, 1991, Annals of the New York Academy of Sciences.

Pharmacological profile of the substituted beta‐lactam L‐659,286: A member of a new class of human PMN elastase inhibitors

L. Schaeffer, W. Hagmann, A. Maycock, 1989, Journal of cellular biochemistry.

An accessible pharmacodynamic transcriptional biomarker for notch target engagement

J. Lunceford, J. Watters, A. Loboda, 2016, Clinical pharmacology and therapeutics.

Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction

D. Johns, J. Wagner, R. Krishna, 2012, Clinical pharmacology and therapeutics.

Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor

C. Beyer, M. Abou-Gharbia, D. Deecher, 2006, Journal of Pharmacology and Experimental Therapeutics.

Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study.

C. Fuchs, E. Van Cutsem, J. Tabernero, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: Primary results from the phase 3 MARIPOSA-2 study.

R. Knoblauch, R. Gentzler, M. Mackean, 2023, Annals of oncology : official journal of the European Society for Medical Oncology.